$KOD

$92.21▲ -0.1% YTD

6 SEC 13D/G filings tracked · Last updated Oct 7, 2026

Filing History

News

KOD ▼ -0.1% - Kodiak Sciences Inc.

CP $92.21▲ -0.1%Oct 7, 2026 · ThinkSabio Blog

$KOD KOD - Kodiak Sciences to Present Clinical Data Across All Three Late-Stage Programs at AAO 2026…

SEC 13D/G

KOD - Kodiak Sciences Inc. - SEC Filing Update (30-SEP-2026) | ThinkSabio - Stocks Simplified

$95.13▲ 265.60%Sep 30, 2026 · ThinkSabio Blog

$KOD SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #KOD Kodiak Sciences Inc. : $95.13 Sector: Healthcare | YTD: 🔼+ 2…

News

KOD ▲ +138.5% - Kodiak Sciences Inc.

CP $77.15▲ +138.5%Sep 28, 2026 · ThinkSabio Blog

$KOD vol pop highs +123%…

News

KOD ▲ +39.1% - Kodiak Sciences Inc.

CP $45.00▲ +39.1%Sep 28, 2026 · ThinkSabio Blog

$KOD KOD - Zenkuda and tabirafusp-ted Meet Primary Endpoints in Pivotal DAYBREAK Trial in wAMD, with Zenkuda Demonstrating a Potential New Standard-of…

News

KOD ▲ +3.7% - Kodiak Sciences Inc.

CP $34.50▲ +3.7%Sep 26, 2026 · ThinkSabio Blog

$KOD Kodiak Sciences (KOD) said it will report topline results from its Phase 3 DAYBREAK study on Monday, September 28, 2026, and hold a webcast at 8:…

News

KOD ▲ +17.2% - Kodiak Sciences Inc.

CP $38.99▲ +17.2%Sep 25, 2026 · ThinkSabio Blog

$KOD KOD - Kodiak Sciences to Present Topline Results on September 28, 2026 from DAYBREAK Pivotal Phase 3 Study of Zenkuda and KSI-501 in Patients wit…